Tiger Pharmaceuticals (03347.HK) plans to sell a 3.41% equity stake in Lixin Pharmaceuticals for $34.11 million.

Wisdom Financial News App, Tata Pharmaceutical (03347.HK) announced that as of the date of this announcement, the company directly holds a 3.41% stake in Leixin Pharmaceutical through Tata Equity; and indirectly holds a 4.58% stake in Leixin Pharmaceutical through holding shares in funds. The company does not have any director seats in Leixin Pharmaceutical.